Lingwood, Daniel
- Massachusetts General Hospital · Microbiology & Immunology (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,303
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$993.3K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,303
By linked amount among FY2023 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lingwood, Daniel as a PI. Multi-PI records show the full award amount for context.
- 5R01AI146785-04R01Contact PIDefining the Fc-correlates of protection against influenzaMassachusetts General Hospital · Microbiology & Immunology (topic-inferred)$601.3Kaward amount
- 5R01AI155447-03R01Contact PISystemic coordination of pro-inflammatory immune reactions through dendritic cell-restricted sIL6R biogenesisMassachusetts General Hospital · Microbiology & Immunology (topic-inferred)$392.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lingwood, Daniel as a PI.
FY2023 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardMassachusetts General Hospital
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #1819
- 2016Entered Top 25% NationallyRanked #1819
- 2016Entered Top 10% NationallyRanked #1819
- 2021R01 Grant Holder